ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,429Medicare Part D Prescriptions Filled, Including Refills

Rank: 534 out of 1456

$292K Total Retail Price of All Prescriptions

Rank: 737 out of 1456

366 Patients Receiving at Least One Drug in Part D
61%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 366 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

12% of this provider’s 366 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 4,734 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
AMLODIPINE BESYLATE 466 339 1 1
SIMVASTATIN 429 286 2 2
METFORMIN HCL 271 182 3 8
LISINOPRIL 224 132 4 3
FUROSEMIDE 203 135 5 7
HYDROCHLOROTHIAZIDE 177 113 6 10
LOSARTAN POTASSIUM 164 135 7 16
HYDROCODONE-ACETAMINOPHEN 141 66 S3 8 6
OMEPRAZOLE 135 99 9 5
LOSARTAN-HYDROCHLOROTHIAZIDE 125 85 10 41
LEVOTHYROXINE SODIUM 113 69 11 4
METOPROLOL TARTRATE 112 76 12 12
PRAVASTATIN SODIUM 105 81 13 9
TRAMADOL HCL 103 58 14 17
GABAPENTIN 100 43 15 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 97 63 16 24
ATENOLOL 96 75 17 18
KLOR-CON 10 94 66 18 96
AMLODIPINE BESYLATE-BENAZEPRIL 89 51 19 61
ATORVASTATIN CALCIUM 81 59 20 11
POTASSIUM CHLORIDE 79 40 21 15
ZOLPIDEM TARTRATE 77 60 22 14
IBUPROFEN 73 35 23 103
CARVEDILOL 72 65 24 20
GLIPIZIDE 66 34 25 53
TAMSULOSIN HCL 63 44 26 34
RANITIDINE HCL 63 54 26 27
ALLOPURINOL 62 51 28 31
DIOVAN 60 35 29 35
LOVASTATIN 58 45 30 40
INSULIN SYRINGE 57 36 31 64
FLUTICASONE PROPIONATE 56 43 32 28
CLONIDINE HCL 56 23 32 39
HYDROCODONE BIT-IBUPROFEN 53 34 S3 34 420
NAPROXEN 53 20 34 100
GLYBURIDE 53 39 R 34 94
HYDRALAZINE HCL 53 48 34 48
KLOR-CON M20 52 32 38 51
CRESTOR 52 24 38 26
TRIAMTERENE-HCTZ 50 39 40 49
LANTUS 50 34 40 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 13, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.